Use of synthetic T-cell epitopes as immunogens to induce antibodies to hepatitis B components.
Milich
D R
DR
Thornton
G B
GB
D000595:Amino Acid Sequence; D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology; D000917:Antibody Formation; D000918:Antibody Specificity; D001483:Base Sequence; D001666:Binding Sites, Antibody / Q000235:genetics; D000939:Epitopes / Q000276:immunology*; D005260:Female; D006511:Hepatitis B Antigens / Q000276:immunology*; D006514:Hepatitis B Surface Antigens / Q000235:genetics / Q000276:immunology; D051379:Mice; D008815:Mice, Inbred Strains; D008969:Molecular Sequence Data; D010455:Peptides / Q000138:chemical synthesis / Q000276:immunology; D012333:RNA, Messenger / Q000235:genetics; D013601:T-Lymphocytes / Q000276:immunology*; D014612:Vaccines; D014614:Vaccines, Synthetic
D000911:Antibodies, Monoclonal; D000939:Epitopes; D006511:Hepatitis B Antigens; D006514:Hepatitis B Surface Antigens; D010455:Peptides; D012333:RNA, Messenger; D014612:Vaccines; D014614:Vaccines, Synthetic